Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02011685 · ClinicalTrials.gov registry record · NA

Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
450
Enrollment target

NCT02011685 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 450 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02011685, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target

Study Summary

This study will assess the comparative effectiveness, cost-effectiveness and sustainability of two telemonitoring interventions in reducing blood pressure and recurrent stroke among 450 high-risk Black and Hispanic stroke patients. The primary hypothesis is that home blood pressure telemonitoring supplemented with individualized, culturally tailored telephone-based nurse case management will have greater effects on blood pressure reduction and stroke recurrence and, while it will be more costly, it will also be more cost-effective than home blood pressure telemonitoring alone. Results of this study will provide strong empirical evidence to inform clinical guidelines and practice, which may lead to reductions in stroke disparities in the United States.

Interventions

  • BEHAVIORAL Home BP Telemonitoring (HBPTM)
  • BEHAVIORAL Nurse Case Management (NCM)

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2014-04-18
Est. Completion 2019-12-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT02011685

The ClinicalTrials.gov registry entry for NCT02011685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Home BP Telemonitoring (HBPTM) is the first listed.

NCT02011685 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02011685 about?

NCT02011685 is a clinical study titled "Practice-Based Trial of Home BP Telemonitoring Among Minority Stroke Survivors". This study will assess the comparative effectiveness, cost-effectiveness and sustainability of two telemonitoring interventions in reducing blood pressure and recurrent stroke among 450 high-risk Black and Hispanic stroke patients. The primary hypothesis is that home blood pressure telemonitoring su...

What is the current status of trial NCT02011685?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2014-04-18. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT02011685?

The interventions under investigation include: Home BP Telemonitoring (HBPTM) (BEHAVIORAL), Nurse Case Management (NCM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02011685?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.